Dr. Margarete Fischer-Bosch-Institute of Clinical PharmacologyGermany
Comprehensive Cancer Center MainfrankenGermany
Georg Speyer HausGermany
Merck Serono S.A. (Switzerland)Switzerland
Transgene (France)France
Institute of Molecular and Clinical Ophthalmology BaselSwitzerland
Nerviano Medical SciencesItaly
The San Raffaele Telethon Institute for Gene TherapyItaly
Swiss Group For Clinical Cancer Researchrelative toRipamontiItalyRipamonti's profile →
Citations per field
00.5×2×2.6×
Ripamonti · 1×
×0.714k/22kONCOL
×0.56k/12kCR
×1.68k/5kIMMUN
×0.95k/5kPFM
×2.63k/1kHEMAT
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at Swiss Group For Clinical Cancer Research
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Swiss Group For Clinical Cancer Research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Swiss Group For Clinical Cancer Research with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swiss Group For Clinical Cancer Research more than expected).
Fields of papers published by authors at Swiss Group For Clinical Cancer Research
This network shows the impact of papers affiliated with Swiss Group For Clinical Cancer Research at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Swiss Group For Clinical Cancer Research at the time of their publication.
About Swiss Group For Clinical Cancer Research
In recent decades, authors affiliated with Swiss Group For Clinical Cancer Research have published 999 papers, which have received a total of 54.4k indexed citations . Scholars at this organization have produced 280 papers in Oncology, 129 papers in Pathology and Forensic Medicine, 102 papers in Cancer Research, 66 papers in Genetics and 117 papers in Immunology on the topics of Lymphoma Diagnosis and Treatment (104 papers), Breast Cancer Treatment Studies (54 papers), Chronic Lymphocytic Leukemia Research (45 papers), T-cell and B-cell Immunology (43 papers), Immune Cell Function and Interaction (42 papers), Immunotherapy and Immune Responses (42 papers), Lung Cancer Treatments and Mutations (41 papers) and Monoclonal and Polyclonal Antibodies Research (38 papers). Their work is cited by papers focused on Oncology (14.4k citations), Cancer Research (6.1k citations), Immunology (7.8k citations), Pathology and Forensic Medicine (4.9k citations) and Hematology (3.1k citations). Authors at Swiss Group For Clinical Cancer Research collaborate with scholars in Switzerland, United States and Italy and have published in prestigious journals including Annals of Oncology, Blood, The Journal of Immunology, European Journal of Cancer and Molecular and Cellular Biology. Some of Swiss Group For Clinical Cancer Research's most productive authors include Kay Hofmann, Rex M. Tyrrell, Stephen M. Keyse, Lukas C. Kühn, Erich A. Nigg, H. Robson MacDonald, Heidi Diggelmann, Richard D Iggo, Markus Nabholz and Egil Kvam.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact